Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    11806971 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Zevalin for Patients With Incomplete Response to Chemo Prior to Autologous Stem Cell Transplant for Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: indium-111-ibritumomab tiuxetan;   Drug: 90Y Zevalin
2 Recruiting High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: BeEAM
3 Unknown  Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells
Condition: Hematologic Diseases
Intervention:
4 Unknown  Busulfan and Melphalan Conditioning in Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: BUSULFEX®;   Drug: Alkeran®

Study has passed its completion date and status has not been verified in more than two years.